Skip to main content
Premium Trial:

Request an Annual Quote

Shimadzu Scientific Instruments LCMS-8060NX Triple Quadrupole LC-MS/MS

Shimadzu Scientific Instruments has launched the LCMS-8060NX triple quadrupole liquid chromatograph mass spectrometer (LC-MS/MS). The system features new ion guides, the UF-Qarray II and the UF-Lens II, to increase robustness while maintaining high ion transmission efficiency. Neutral particles are expelled to reduce noise and provide high stability. A new heat-assist design increases desolvation efficiency and promotes superior ionization of a wide range of compounds. In addition, the system's UFsweeper technology effectively sweeps ions from the collision cell without deceleration, maintaining high-sensitivity analysis even at high acquisition speeds, Shimadzu said. Consumable parts like the ESI spray needle and the inlet desolvation line can be changed quickly and easily without breaking vacuum, the company noted. Other features include optimized parameters based on AI research that enable high sensitivity without manual optimization; automated start-up and shutdown (with LabSolutions Connect MRM) for unattended operation; and multiple analytical intelligence functions to further increase workflow efficiency. Shimadzu also introduced updated LabSolutions LCMS workstation software for total operator support, from analysis to data processing. The LabSolutions Connect/LabSolutions Insight platform supports the entire analysis workflow, including project file management, optimization of MRM and interface parameters, efficient verification of quantitative results, simple method and batch creation, and verification of quantitative results.
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.